Treatment News : New Highly Sensitive, Low-Cost HIV Test Gives Early, Naked Eye Results

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » October 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


October 29, 2012

New Highly Sensitive, Low-Cost HIV Test Gives Early, Naked Eye Results

English researchers have developed a groundbreaking new HIV test with manifold benefits that include results visible to the naked eye, a reduced “window period” after infection and a dramatically lowered cost that could greatly benefit developing nations. According to a paper published in Nature Nanotechnology, the research team from Imperial College London has developed a prototype test that, in contrast to the standard ELISA nucleic acid-based test, analyzes blood serum for an HIV biomarker known as p24. If the biomarker is present, a reaction within a vial of solution causes nanoparticles to draw together into irregular clusters and develop a visible blue color. Negative results are visibly red when these nanoparticles instead separate into spherical shapes. Because the test is able to detect even the most minute particles of p24, it promises to significantly reduce the window period—the period directly after infection when tests might fail to detect antibodies and thus give false negative results. Furthermore, the new test is one-tenth the cost. To that end, the researchers intend to team with nonprofit global health groups to put the test into wide use in low-income countries.

For a copy of the study, click here

To read the press release, click here

Search: HIV, HIV test, ELISA, antibody, nanoparticle, p24, biomarker, Imperial College London, early results, lowered cost, red, blue, Nature Nanotechnology

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.